Progressive supranuclear palsy (PSP) is a late‐onset neurodegenerative disease defined pathologically by the presence of insoluble phosphorylated‐Tau (p‐Tau) in neurons and glia. Here, MAPT is linked to Classical progressive supranuclear palsy.